Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
11.54 USD | +1.81% | +3.17% | +2.98% |
05/04 | Arbutus Biopharma Obtains Favorable Court Order in Moderna Patent Lawsuit | MT |
04/04 | Moderna Suffers Setback in Lawsuit by Arbutus | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.98% | 913.02Cr | |
+31.61% | 59TCr | |
-2.90% | 36TCr | |
+18.58% | 33TCr | |
+4.74% | 29TCr | |
+15.11% | 24TCr | |
+10.25% | 21TCr | |
-7.20% | 20TCr | |
+9.09% | 17TCr | |
-0.59% | 16TCr |
- Stock Market
- Equities
- ROIV Stock
- News Roivant Sciences Ltd.
- BofA Securities Starts Roivant Sciences at Neutral With $10.50 Price Target